David M. Biondi

3.0k total citations · 2 hit papers
61 papers, 2.2k citations indexed

About

David M. Biondi is a scholar working on Psychiatry and Mental health, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, David M. Biondi has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Psychiatry and Mental health, 30 papers in Physiology and 25 papers in Pathology and Forensic Medicine. Recurrent topics in David M. Biondi's work include Migraine and Headache Studies (40 papers), Pain Mechanisms and Treatments (15 papers) and Musculoskeletal pain and rehabilitation (15 papers). David M. Biondi is often cited by papers focused on Migraine and Headache Studies (40 papers), Pain Mechanisms and Treatments (15 papers) and Musculoskeletal pain and rehabilitation (15 papers). David M. Biondi collaborates with scholars based in United States, Belgium and Germany. David M. Biondi's co-authors include Roger Cady, Jeff Smith, Joe Hirman, Elizabeth Loder, Barbara Schaeffler, Brent Allan, Susan Pederson, Richard B. Lipton, Joel R. Saper and Peter J. Goadsby and has published in prestigious journals such as Neurology, Frontiers in Immunology and Movement Disorders.

In The Last Decade

David M. Biondi

61 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of eptinezumab in patients with chronic migraine

2020 273 citations Richard B. Lipton, Peter J. Goadsby et al. Neurology profile →
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

2020 264 citations Joel R. Saper, Roger Cady et al. profile →

Peers

David M. Biondi

PMH

PFM

PHYSI

PHARM

SURGE

Fabio Antonaci Italy

José Geraldo Speciali Brazil

LJ Stovner Norway

Paola Torelli Italy

TJ Steiner United Kingdom

RB Lipton United States

Gian Camillo Manzoni Italy

Aubrey Manack United States

Christian Lampl Austria

Franco Granella Italy

Fabio Antonaci Italy

David M. Biondi

2.5k ×1.6

PMH

1.7k ×1.6

PFM

1.2k ×1.5

PHYSI

408 ×1.4

PHARM

384 ×1.4

SURGE

Citations per year, relative to David M. Biondi David M. Biondi (= 1×) peers Fabio Antonaci

Countries citing papers authored by David M. Biondi

Since Specialization

Citations

This map shows the geographic impact of David M. Biondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Biondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Biondi more than expected).

Fields of papers citing papers by David M. Biondi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Biondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Biondi. The network helps show where David M. Biondi may publish in the future.

Co-authorship network of co-authors of David M. Biondi

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Biondi. A scholar is included among the top collaborators of David M. Biondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Biondi. David M. Biondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pederson, Susan, David M. Biondi, Brent Allan, et al.. (2021). Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine. Frontiers in Immunology. 12. 765822–765822. 2 indexed citations

Silberstein, Stephen D., Merle L. Diamond, Nada Hindiyeh, et al.. (2020). Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study. The Journal of Headache and Pain. 21(1). 120–120. 72 indexed citations

Lipton, Richard B., Peter J. Goadsby, Jeff Smith, et al.. (2020). Efficacy and safety of eptinezumab in patients with chronic migraine. Neurology. 94(13). e1365–e1377. 273 indexed citations breakdown →

Dodick, David W., Timothy R. Smith, Roger Cady, et al.. (2019). Eptinezumab Demonstrates Early Relief from Episodic and Chronic Migraine: Consistency of Effect Across 4 Clinical Trials (S17.004). Neurology. 92(15_supplement). 3 indexed citations

Lipton, Richard B., et al.. (2019). PND81 PATIENT GLOBAL IMPRESSION OF CHANGE RELATED TO IMPROVEMENT IN MOST BOTHERSOME SYMPTOM FOLLOWING TREATMENT WITH EPTINEZUMAB. Value in Health. 22. S285–S285. 1 indexed citations

Joshi, Kruti, et al.. (2018). The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia. BMC Psychiatry. 18(1). 24–24. 7 indexed citations

Biondi, David M., Jim Xiang, Mila Etropolski, & Bruce L. Moskovitz. (2015). Tolerability and efficacy of tapentadol extended release in elderly patients ≥75 years of age with chronic osteoarthritis knee or low back pain. Journal of Opioid Management. 11(5). 393–403. 27 indexed citations

Salinas, Gregory D., et al.. (2012). Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: A national multifaceted assessment of physicians, pharmacists, and their patients. Journal of Opioid Management. 8(5). 273–284. 15 indexed citations

Anastassopoulos, Kathryn, Wing Chow, Rebecca Baik, et al.. (2012). Economic Study on the Impact of Side Effects in Patients Taking Oxycodone Controlled-Release for Noncancer Pain. Journal of Managed Care Pharmacy. 18(8). 615–626. 22 indexed citations

10.

Elble, Rodger J., et al.. (2010). Carisbamate in essential tremor: Brief report of a proof of concept study. Movement Disorders. 25(5). 634–638. 15 indexed citations

11.

Marmura, Michael J., Mary Hopkins, Jocelyn Andrel, et al.. (2010). Electronic Medical Records as a Research Tool: Evaluating Topiramate Use at a Headache Center. Headache The Journal of Head and Face Pain. 50(5). 769–778. 6 indexed citations

12.

Cady, Roger, Frederick G. Freitag, Ninan T. Mathew, et al.. (2009). Allodynia‐Associated Symptoms, Pain Intensity and Time to Treatment: Predicting Treatment Response in Acute Migraine Intervention. Headache The Journal of Head and Face Pain. 49(3). 350–363. 23 indexed citations

13.

Dodick, David W., Fred Freitag, James Banks, et al.. (2009). Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clinical Therapeutics. 31(3). 542–559. 103 indexed citations

14.

Diamond, Merle L., Roger Cady, Lian Mao, et al.. (2008). Characteristics of Migraine Attacks and Responses to Almotriptan Treatment: A Comparison of Menstrually Related and Nonmenstrually Related Migraines. Headache The Journal of Head and Face Pain. 48(2). 248–258. 50 indexed citations

15.

Biondi, David M.. (2005). Physical Treatments for Headache: A Structured Review. Headache The Journal of Head and Face Pain. 45(6). 738–746. 111 indexed citations

16.

Loder, Elizabeth & David M. Biondi. (2004). Off‐Label Prescribing of Drugs in Specialty Headache Practice. Headache The Journal of Head and Face Pain. 44(7). 636–641. 24 indexed citations

17.

Evans, Randolph W., Elizabeth Loder, & David M. Biondi. (2004). When Can Successful Migraine Prophylaxis Be Discontinued?. Headache The Journal of Head and Face Pain. 44(10). 1040–1042. 11 indexed citations

18.

Loder, Elizabeth & David M. Biondi. (2003). Disease Modification in Migraine: A Concept That Has Come of Age?. Headache The Journal of Head and Face Pain. 43(2). 135–143. 25 indexed citations

19.

Loder, Elizabeth & David M. Biondi. (2003). Oral Phenobarbital Loading: A Safe and Effective Method of Withdrawing Patients With Headache From Butalbital Compounds. Headache The Journal of Head and Face Pain. 43(8). 904–909. 12 indexed citations

20.

Biondi, David M.. (2003). Opioid resistance in chronic daily headache: A synthesis of ideas from the bench and bedside. Current Pain and Headache Reports. 7(1). 67–75. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact